Marine-Derived Natural Compounds for the Treatment of Parkinson’s Disease
AbstractParkinson’s disease (PD) is a neurodegenerative disorder caused by the loss of dopaminergic neurons, leading to the motor dysfunctions of patients. Although the etiology of PD is still unclear, the death of dopaminergic neurons during PD progress was revealed to be associated with the abnormal aggregation of α-synuclein, the elevation of oxidative stress, the dysfunction of mitochondrial functions, and the increase of neuroinflammation. However, current anti-PD therapies could only produce symptom-relieving effects, because they could not provide neuroprotective effects, stop or delay the degeneration of dopaminergic neurons. Marine-derived natural compounds, with their novel chemical structures and unique biological activities, may provide anti-PD neuroprotective effects. In this study, we have summarized anti-PD marine-derived natural products which have shown pharmacological activities by acting on various PD targets, such as α-synuclein, monoamine oxidase B, and reactive oxygen species. Moreover, marine-derived natural compounds currently evaluated in the clinical trials for the treatment of PD are also discussed. View Full-Text
Share & Cite This Article
Huang, C.; Zhang, Z.; Cui, W. Marine-Derived Natural Compounds for the Treatment of Parkinson’s Disease. Mar. Drugs 2019, 17, 221.
Huang C, Zhang Z, Cui W. Marine-Derived Natural Compounds for the Treatment of Parkinson’s Disease. Marine Drugs. 2019; 17(4):221.Chicago/Turabian Style
Huang, Chunhui; Zhang, Zaijun; Cui, Wei. 2019. "Marine-Derived Natural Compounds for the Treatment of Parkinson’s Disease." Mar. Drugs 17, no. 4: 221.
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.